Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
Klekotka
P A
PA
Department of Pharmacology and Toxicology, University of Arizona, Tucson 85721, USA.
Halpert
J R
JR
D000735:Androstenedione / Q000378:metabolism; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000378:metabolism*; D004285:Dogs; D004790:Enzyme Induction / Q000187:drug effects; D066298:In Vitro Techniques; D007700:Kinetics; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D010078:Oxazines / Q000378:metabolism*; D010634:Phenobarbital / Q000494:pharmacology*; D013250:Steroid Hydroxylases / Q000096:biosynthesis / Q000378:metabolism*; D013379:Substrate Specificity
D010078:Oxazines; D000735:Androstenedione; C057754:benzyloxyresorufin; D003577:Cytochrome P-450 Enzyme System; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C025619:steroid 16-beta-hydroxylase; D010634:Phenobarbital